The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Two-year review of the electronic Patient Reported Outcome (ePRO) system in the Prostate Clinic at the Vancouver Prostate Centre (VPC).
 
Eugenia Wu
No Relationships to Disclose
 
Olga Arsovska
No Relationships to Disclose
 
Lindsay Hedden
No Relationships to Disclose
 
Maria Spillane
No Relationships to Disclose
 
Michaela Vivar
No Relationships to Disclose
 
Martin Gleave
Stock and Other Ownership Interests - OncoGenex
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Genova Diagnostics; Janssen; MDxHealth; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Genova Diagnostics; Janssen; MDxHealth; Sanofi
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - OncoGenex - OGX-011, OGX-427
 
Peter C. Black
Consulting or Advisory Role - Abbvie; Amgen; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Biosyent; Bristol-Myers Squibb; Ferring; Janssen Oncology; MDxHealth; Merck; Roche Canada; Sanofi; Urogen pharma
Speakers' Bureau - TerSera
Research Funding - GenomeDx; iProgen; Sitka
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
Travel, Accommodations, Expenses - Sanofi
 
Alan So
Honoraria - Astellas Amgen BioPharama; Janssen
 
Larry Goldenberg
Leadership - Genyous
 
Celestia S. Higano
Employment - CTI (I)
Leadership - CTI (I)
Stock and Other Ownership Interests - CTI (I)
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; Clovis Oncology; Ferring; Hinova Pharmaceuticals; Janssen; Myriad Genetics; Pfizer; Tolmar
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Dendreon (Inst); Emergent BioSolutions (Inst); Medivation (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Blue Earth Diagnostics; Clovis Oncology; Ferring; Hinova Pharmaceuticals; Menarini; Myriad Genetics; Pfizer